SBFM financials
Sunshine Biopharma (SBFM) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- SBFM revenue was $36.31M in fiscal 2025, net income -$5.98M.
SBFM income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $36.31M | $12.26M | -$6.23M | -$5.98M | -288.00 |
| 2024 | $34.87M | $10.67M | -$5.81M | -$5.13M | -1464.00 |
| 2023 | $24.09M | $8.34M | -$4.79M | -$4.51M | -70272.00 |
| 2022 | $4.35M | $1.70M | -$27.00M | -$26.74M | -352.00 |
| 2021 | $228.43K | $110.60K | -$2.44M | -$12.44M | -952.00 |
| 2020 | $71.41K | $45.56K | -$576.87K | -$2.78M | -546.00 |